Skip to content
healthcare.dev

ZYNLONTA

NDC 79952-110, loncastuximab tesirine, injection, powder, lyophilized, for solution, from ADC Therapeutics America, Inc..

Product NDC
79952-110
Status
Listed
Labeler
ADC Therapeutics America, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761196
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/79952-110 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LONCASTUXIMAB TESIRINE10 mg/2mL
Package NDCNDC-11Package
79952-110-01799520110011 VIAL, SINGLE-DOSE in 1 CARTON (79952-110-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/af54af12-3edf-4301-8bc5-0446bc813c1d
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=79952-110

Use it

Look up 79952-110 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/79952-110 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 79952-110. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.